This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Klugbauer, S. Articles by Rabes, H. M. Search for Related Content PubMed Articles by Klugbauer, S. Articles by Rabes, H. M.

Detection of a Novel Type of RET Rearrangement (PTC5) in Thyroid Carcinomas after Chernobyl and Analysis of the Involved RET-fused Gene RFG5¹

Institute of Pathology [S. K., H. M. R.] and Institute of Radiation Biology [E. L.], Ludwig Maximilians University of Munich, D-80337 Munich, Germany, and Chair of Oncology, Medical High School of Minsk, Belarus [E. P. D.]

A novel type of RET rearrangement, PTC5, was detected in papillary thyroid carcinomas of two patients exposed to radioactive fallout after Chernobyl. Reverse transcription-PCR and rapid amplification of 5'-cDNA ends revealed a fusion of the ret tyrosine kinase (TK) domain with a sequence identical to that described previously as ret-II. Ret-II is a transfection artifact in NIH3T3 cells and has not yet been detected in any human tumor. Overlapping sequences found in the expressed sequence tag databases enabled us to sequence the COOH terminus of the ret-fused gene 5 (RFG5). The combined data made it possible to assemble a full-length rfg5 protein sequence. Computer-assisted analysis of this sequence reveals four putative coiled-coil structures, possibly involved in dimerization, but no membrane-binding sequences. Northern blots show a ubiquitous RFG5 expression in various normal tissues, including the thyroid gland. In addition to the RFG5/RET, we also detected the reciprocal RET/RFG5 transcript in both tumor samples, suggesting that the rearrangement is based on a balanced reciprocal translocation. In agreement with other rearranged TKs, it is concluded that the transforming action of the new fusion protein rfg5/ret in thyroid tumors may be due to an activation of the ret TK by constitutive expression and dimerization potential of the 5'-fused rfg5 protein. Ret immunohistochemistry indicates that the fusion protein is expressed in all cells of PTC5 tumors, suggesting that RFG5/RET rearrangement is an early event in thyroid carcinogenesis.

¹ This work was supported by grants (to H. M. R.) from the Dr. Mildred Scheel-Stiftung für Krebsforschung, Bonn, Germany, and from the Wilhelm Sander-Stiftung, Neuburg an der Donau, Germany.

² To whom requests for reprints should be addressed, at Institute of Pathology, Ludwig Maximilians University of Munich, Thalkirchner Str. 36, D-80337 München, Germany. Phone: 49-89/5160-4081; Fax: 49-89/5160-4083.

Received 10/ 2/97. Accepted 12/ 2/97.

This article has been cited by other articles:

				G. Riesco-Eizaguirre and P. Santisteban New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy Endocr. Relat. Cancer, December 1, 2007; 14(4): 957 - 977. [Abstract] [Full Text] [PDF]

				R. Ciampi, T. J Giordano, K. Wikenheiser-Brokamp, R. J Koenig, and Y. E Nikiforov HOOK3-RET: a novel type of RET/PTC rearrangement in papillary thyroid carcinoma Endocr. Relat. Cancer, June 1, 2007; 14(2): 445 - 452. [Abstract] [Full Text] [PDF]

				Y. Du, S. E. Spence, N. A. Jenkins, and N. G. Copeland Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis Blood, October 1, 2005; 106(7): 2498 - 2505. [Abstract] [Full Text] [PDF]

				S. Sadetzki, R. Calderon-Margalit, B. Modan, S. Srivastava, and R. M. Tuttle Ret/PTC Activation in Benign and Malignant Thyroid Tumors Arising in a Population Exposed to Low-Dose External-Beam Irradiation in Childhood J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2281 - 2289. [Abstract] [Full Text] [PDF]

				J. Wang, J. A. Knauf, S. Basu, E. Puxeddu, H. Kuroda, M. Santoro, A. Fusco, and J. A. Fagin Conditional Expression of RET/PTC Induces a Weak Oncogenic Drive in Thyroid PCCL3 Cells and Inhibits Thyrotropin Action at Multiple Levels Mol. Endocrinol., July 1, 2003; 17(7): 1425 - 1436. [Abstract] [Full Text] [PDF]

				C. Carniti, C. Perego, P. Mondellini, M. A. Pierotti, and I. Bongarzone PP1 Inhibitor Induces Degradation of RETMEN2A and RETMEN2B Oncoproteins through Proteosomal Targeting Cancer Res., May 1, 2003; 63(9): 2234 - 2243. [Abstract] [Full Text] [PDF]

				A. K. Gillingham, A. C. Pfeifer, and S. Munro CASP, the Alternatively Spliced Product of the Gene Encoding the CCAAT-Displacement Protein Transcription Factor, Is a Golgi Membrane Protein Related to Giantin Mol. Biol. Cell, November 1, 2002; 13(11): 3761 - 3774. [Abstract] [Full Text] [PDF]

				J. A. Fagin Perspective: Lessons Learned from Molecular Genetic Studies of Thyroid Cancer--Insights into Pathogenesis and Tumor-Specific Therapeutic Targets Endocrinology, June 1, 2002; 143(6): 2025 - 2028. [Full Text] [PDF]

				G. Chiappetta, P. Toti, F. Cetta, A. Giuliano, F. Pentimalli, I. Amendola, S. Lazzi, M. Monaco, L. Mazzuchelli, P. Tosi, et al. The RET/PTC Oncogene Is Frequently Activated in Oncocytic Thyroid Tumors (Hurthle Cell Adenomas and Carcinomas), but Not in Oncocytic Hyperplastic Lesions J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 364 - 369. [Abstract] [Full Text] [PDF]

				R. Elisei, C. Romei, T. Vorontsova, B. Cosci, V. Veremeychik, E. Kuchinskaya, F. Basolo, E. P. Demidchik, P. Miccoli, A. Pinchera, et al. RET/PTC Rearrangements in Thyroid Nodules: Studies in Irradiated and Not Irradiated, Malignant and Benign Thyroid Lesions in Children and Adults J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3211 - 3216. [Abstract] [Full Text] [PDF]

				S. Klugbauer, A. Jauch, E. Lengfelder, E. Demidchik, and H. M. Rabes A Novel Type of RET Rearrangement (PTC8) in Childhood Papillary Thyroid Carcinomas and Characterization of the Involved Gene (RFG8) Cancer Res., December 1, 2000; 60(24): 7028 - 7032. [Abstract] [Full Text]

				D. Salvatore, M. V. Barone, G. Salvatore, R. M. Melillo, G. Chiappetta, A. Mineo, G. Fenzi, G. Vecchio, A. Fusco, and M. Santoro Tyrosines 1015 and 1062 Are in VivoAutophosphorylation Sites in Ret and Ret-Derived Oncoproteins J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3898 - 3907. [Abstract] [Full Text]

				E. L. Chua, W. M. Wu, K. T. Tran, S. W. McCarthy, C. S. Lauer, D. Dubourdieu, N. Packham, C. J. O’Brien, J. R. Turtle, and Q. Dong Prevalence and Distribution of ret/ptc 1, 2, and 3 in Papillary Thyroid Carcinoma in New Caledonia and Australia J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2733 - 2739. [Abstract] [Full Text]

				K. Salassidis, J. Bruch, H. Zitzelsberger, E. Lengfelder, A. M. Kellerer, and M. Bauchinger Translocation t(10;14)(q11.2;q22.1) Fusing the Kinectin to the RET Gene Creates a Novel Rearranged Form (PTC8) of the RET Proto-Oncogene in Radiation-induced Childhood Papillary Thyroid Carcinoma Cancer Res., June 1, 2000; 60(11): 2786 - 2789. [Abstract] [Full Text] [PDF]

				H. M. Rabes, E. P. Demidchik, J. D. Sidorow, E. Lengfelder, C. Beimfohr, D. Hoelzel, and S. Klugbauer Pattern of Radiation-induced RET and NTRK1 Rearrangements in 191 Post-Chernobyl Papillary Thyroid Carcinomas: Biological, Phenotypic, and Clinical Implications Clin. Cancer Res., March 1, 2000; 6(3): 1093 - 1103. [Abstract] [Full Text]

				O. Gimm, A. Greco, C. Hoang-Vu, H. Dralle, M. A. Pierotti, and C. Eng Mutation Analysis Reveals Novel Sequence Variants in NTRK1 in Sporadic Human Medullary Thyroid Carcinoma J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2784 - 2787. [Abstract] [Full Text]

				F. Cetta, M. Gori, N. Raffaelli, C. Baldi, G. Montalto, D. L Learoyd, and B. G Robinson RET/PTC and RET Tyrosine Kinase Expression in Adult Papillary Thyroid Carcinomas--Authors' Response J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2258 - 2258. [Full Text]

				F. Cetta, M. Gori, N. Raffaelli, C. Baldi, and G. Montalto Comment on Clinical and Prognostic Relevance of Ret-PTC Activation in Patients with Papillary Thyroid Carcinoma J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2257a - 2258. [Full Text]

				C. Eng RET Proto-Oncogene in the Development of Human Cancer J. Clin. Oncol., January 1, 1999; 17(1): 380 - 380. [Abstract] [Full Text] [PDF]

				S. L. Sugg, S. Ezzat, I. B. Rosen, J. L. Freeman, and S. L. Asa Distinct Multiple RET/PTC Gene Rearrangements in Multifocal Papillary Thyroid Neoplasia J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4116 - 4122. [Abstract] [Full Text]

				A. H. Fischer, J. A. Bond, P. Taysavang, O. E. Battles, and D. Wynford-Thomas Papillary Thyroid Carcinoma Oncogene (RET/PTC) Alters the Nuclear Envelope and Chromatin Structure Am. J. Pathol., November 1, 1998; 153(5): 1443 - 1450. [Abstract] [Full Text] [PDF]

				D. L. Learoyd, M. Messina, J. Zedenius, A. I. Guinea, L. W. Delbridge, and B. G. Robinson RET/PTC and RET Tyrosine Kinase Expression in Adult Papillary Thyroid Carcinomas J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3631 - 3635. [Abstract] [Full Text]